Skip to main content
UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center

News releases

July 2015arrow

UC Davis researchers awarded grant for HIV clinical trial using stem cells

July 23, 2015

The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved funding a UC Davis Health System research team to conduct a clinical trial using bioengineered stem cells to treat HIV patients suffering from lymphoma, one of the deadly conditions associated with the disease.

One of America's top hospitals

July 21, 2015

UC Davis medical Center has again ranked as one of the best hospitals in the U.S. for 2015-16 in 10 adult medical specialties by U.S. News & World Report.

Radiation Oncology faculty earn key leadership roles

July 10, 2015

Two faculty members of the UC Davis Department of Radiation Oncology have been recognized for their leadership and expertise in cancer research and care.

UC Davis researchers find key mechanism that causes neuropathic pain

July 6, 2015

Scientists at the University of California, Davis, have identified a key mechanism in neuropathic pain. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple sclerosis or other conditions that cause nerve damage.

June 2015arrow

Knoepfler awarded childhood cancer research grant

June 25, 2015

UC Davis stem cell scientist Paul Knoepfler has been awarded $250,000 for glioma research from an organization begun 15 years ago by a 5-year-old girl with a deadly form of childhood cancer.

Leiserowitz receives WAGO award

June 15, 2015

Gary Leiserowitz, chief of gynecologic oncology and interim chair of the Department of Obstetrics and Gynecology, received the Western Association of Gynecologic Oncologists (WAGO) James F. Nolan Award June 12 at the 2015 Annual Meeting in Santa Rosa.

UC Davis Division of Pediatric Hematology-Oncology welcomes new chief

June 15, 2015

Marcio H. Malogolowkin, an international leader in the treatment of rare pediatric liver tumors, has joined UC Davis as the new chief of the UC Davis Division of Pediatric Hematology and Oncology.

May 2015arrow

Revealing kidney cancer's secret

May 14, 2015

An international team of scientists, led by UC Davis nephrologist Robert Weiss, have used a sophisticated combination of proteomics and metabolomics to show how renal cell carcinoma (RCC) reprograms its metabolism and evades the immune system. In addition, the study found that cancer grade has a major impact on this reprogramming. These results, published in the journal Cancer Research, point to new therapeutic options for this particularly deadly cancer.

Surgery for terminal cancer patients still common

May 1, 2015

The number of surgeries performed on terminally ill cancer patients has not dropped in recent years ­, despite more attention to the importance of less invasive care for these patients to relieve symptoms and improve quality of life. But new research from UC Davis also finds that the morbidity and mortality among patients with terminal cancer has declined because surgeons are selecting to operate on healthier patients.

April 2015arrow

NCI funding boosts breast CT scanning research and development

April 29, 2015

John M. Boone, a UC Davis medical physicist and professor of radiology, has been awarded a $2.88 million grant from the National Cancer Institute to further develop and research computed tomography (CT) to detect breast cancer.

Comprehensive genomic tumor profiling comes to UC Davis

April 20, 2015

The UC Davis Comprehensive Cancer Center and the Department of Pathology and Laboratory Medicine have entered into a collaboration with Foundation Medicine, a leading molecular information company. The collaboration brings comprehensive genomic profiling into standard of care at UC Davis, allowing physicians to prescribe the most effective, targeted cancer treatments to patients based on the genomic information specific to each individual’s cancer.

UC Davis researchers win grant to answer key questions in surveillance of small lung nodules

April 15, 2015

Two UC Davis researchers will help run a major national study to improve surveillance practices for patients with small lung nodules identified on CT imaging and extremely low risk for lung cancer.

Conquer Cancer Foundation selects UC Davis med student for award

April 7, 2015

The Conquer Cancer Foundation has selected UC Davis medical student Angel Morán for the 2015 American Society of Clinical Oncology (ASCO) Medical Student Rotation for Underrepresented Populations.

Small RNA plays big role suppressing cancer

April 2, 2015

The micro RNA miR-22 has long been known for its ability to suppress cancer. However, questions remain about how it achieves this feat. For example, which molecules are regulating miR-22, and which are miR22 targets?

March 2015arrow

Protein may improve liver regeneration

March 31, 2015

Researchers at UC Davis have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPARα, which activates liver regeneration. Normally, mouse PPARα is far more active and efficient than the human form, allowing mice to quickly regenerate damaged livers. However, the research shows that protein fibroblast growth factor 21 (FGF21) can boost the regenerative effects of human PPARα.

UC Davis scientists describe novel drug mechanism that fights brain cancer

March 3, 2015

Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells – responsible for a usually fatal type of brain cancer – and could be applicable to other highly aggressive cancers.

February 2015arrow

UC Davis designated a Lung Cancer Screening Center

February 11, 2015

UC Davis Health System has been endorsed by the American College of Radiology as a designated lung cancer screening center, the only of its kind currently in the greater Sacramento area.

January 2015arrow

California breast density law slow to have an impact

January 28, 2015

Ten months after California legislators enacted a controversial law mandating that radiologists notify women if they have dense breast tissue, UC Davis researchers have found that half of primary care physicians are still unfamiliar with the law and many don’t feel comfortable answering breast density-related questions from patients.

Moon Chen's research featured in ASCO's 2015 cancer progress report

January 21, 2015

UC Davis professor Moon Chen’s research on the under-representation of minorities in clinical trials appears in the American Society in Clinical Oncology (ASCO)’s annual cancer progress report released Tuesday.

December 2014arrow

Too much, too little, just right

December 15, 2014

Scientists have long known the p53 protein suppresses tumors. However, a recent animal study by UC Davis researchers has uncovered a complicated relationship between p53 and another protein, Rbm38, highlighting how the body calibrates protein levels. Too much Rbm38 reduces p53 levels, increasing the risk of cancer. Too little Rbm38 allows p53 overexpression, causing premature aging. The study was published in the journal PNAS on Dec. 15. 

November 2014arrow

'Tis the season to indulge in walnuts

November 13, 2014

Researchers at UC Davis and other institutions have found that diets rich in whole walnuts or walnut oil slowed prostate cancer growth in mice. In addition, both walnuts and walnut oil reduced cholesterol and increased insulin sensitivity.

UC Davis "out-of-the-box thinker" wins cancer research award

November 12, 2014

UC Davis medical oncologist Jonathan Riess is the recipient of a 2014 Young Innovators Team Award for Lung Cancer Research, and will share a $500,000 for translational lung cancer research with two other physician-scientists.

Lung cancer screening for Medicare patients coming soon to UC Davis

November 10, 2014

UC Davis Medical Center is preparing to screen seniors on Medicare who meet the criteria for lung cancer screening using low-dose computed tomography (CT).

Immunotherapy for cancer toxic with obesity

November 3, 2014

Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study by UC Davis researchers has found. [en español]

October 2014arrow

UC Davis researchers examine risks, benefits of chemotherapy for early-stage breast cancer

October 31, 2014

Treatment for early stage breast cancer is highly effective, and for many women considering treatment choices, chemotherapy may add little to an already high long-term survival rate. Joy Melnikow, professor in the Department of Family and Community Medicine and Director of the Center for Healthcare Policy and Research at UC Davis, is working to define the potential long-term harms of chemotherapy for these patients, so they can be weighed against the potential benefits.

Study on Western diet and role in GI cancer funded

October 28, 2014

The National Cancer Institute (NCI) has awarded a $2.7 million grant to UC Davis researchers to investigate how the so-called Western diet, which is high in fat and sugar, increases the risk of developing liver and gastrointestinal (GI) cancers. In addition, the researchers will study whether bifidobacteria, a common family of bacteria in the human gut, can be enriched to prevent cancer.

Anti-cancer drug found effective against common stem cell transplant complication

October 24, 2014

Researchers at UC Davis have found that the drug bortezomib effectively treats chronic graft-versus-host disease (GVHD), a common and debilitating side effect from allogeneic hematopoietic stem cell transplants.

Distinguished cancer prevention researcher to lead public health sciences at UC Davis

October 21, 2014

Brad Pollock, a leading researcher on the incidence and control of childhood and adolescent cancer, has become chair of the Department of Public Health Sciences at the UC Davis School of Medicine.

NCI awards UC Davis $1.5 million to innovate robotic surgery for head and neck cancers

October 21, 2014

The National Cancer Institute (NCI) has awarded UC Davis principal investigators Laura Marcu and Gregory Farwell $1.5 million to adapt UC Davis-developed biophotonic technology to a robotic surgical device in hopes of dramatically improving the precision of head and neck cancer surgery.

Cancer Center wins $1.7 million NCI grant to study novel cancer treatment

October 10, 2014

A multidisciplinary team at UC Davis will embark on research to determine whether combining a novel type of immunotherapy with radiation and chemotherapy can make treatment for sarcoma, breast and pancreatic cancers more effective.

September 2014arrow

Cancer center's Brain Innovation Group funded for brain tumor tool

September 24, 2014

The UC Davis Comprehensive Cancer Center’s Brain Innovation Group has received a grant from the National Cancer Institute (NCI) to improve brain cancer surgery and treatment using UC Davis-developed biophotonic technology.

UC Davis-developed target leukemia treatment shows promise

September 11, 2014

Noriko Satake, UC Davis pediatric oncologist and researcher, has demonstrated in laboratory studies that a new, targeted treatment for leukemia is effective.